Eric Reid, G. M. W. Cook, D. J. Morre
Investigation and Exploitation of Antibody Combining Sites (eBook, PDF)
40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
20 °P sammeln
40,95 €
Als Download kaufen
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
20 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
20 °P sammeln
Eric Reid, G. M. W. Cook, D. J. Morre
Investigation and Exploitation of Antibody Combining Sites (eBook, PDF)
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Zur Zeit liegt uns keine Inhaltsangabe vor.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 33.31MB
Zur Zeit liegt uns keine Inhaltsangabe vor.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer US
- Seitenzahl: 359
- Erscheinungstermin: 9. März 2013
- Englisch
- ISBN-13: 9781468450064
- Artikelnr.: 44178878
- Verlag: Springer US
- Seitenzahl: 359
- Erscheinungstermin: 9. März 2013
- Englisch
- ISBN-13: 9781468450064
- Artikelnr.: 44178878
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
#A Antibody Combining Sites, Especially Structure.
#A
1 Antibody combining sites
past, present and future.
#A
2 Variability, modelling and prediction of ?
hairpins with reference to the immunoglobulin fold.
#A
3 Probing the binding sites in crystals of immunoglobulins.
#A
4 Comparative structures of mouse antibody combining sites.
#NC(A) NOTE and COMMENTS related to the foregoing topics*.
#NC(A)
1 An approach to the study of anti
protein antibody combining sites.
#B Production and Characterization of Antibodies, in Contexts such as Receptor Investigation.
#B
1 Investigating the specificity of monoclonal antibodies to protein antigens using ?
galactosidase fusion proteins.
#B
2 Antibody
screening cDNA libraries.
#B
3 Anti
receptor antibodies by the auto
anti
idiotypic route.
#B
4 Production and characterization of anti
morphine anti
idiotypic antibodies.
#B
5 Anti
idiotype antibodies for the study of membrane receptors: the double monoclonal antibody approach.
#NC(B) NOTES and COMMENTS related to the foregoing topics.
#NC(B)
1 Characterization of idiotypes and VH genes of various members of A48
idiotypic network pathway.
#NC(B)
2 Monoclonal internal image anti
idiotypic antibodies of hepatitis B surface antigen.
#NC(B)
3 Structure and expression of genes encoding IgA heavy chains.
#NC(B)
4 Human:mouse antibody
producing transfectoma cell lines.
#NC(B)
5 Different ways to modify monoclonal antibodies.
#NC(B)
6 Restructuring enzymes and antibodies.
#NC(B)
7 Dideoxy mRNA sequencing as a method to analyze antibody diversity.
#NC(B)
8 Effect of multivalent binding on dissociation of monoclonal antibodies from cell surface antigens.
#C Cytoskeletal, Myocyte and Neuronal Studies with Antibodies.
#C
1Immunological approaches and techniques employed in tubulin and microtubule research.
#C
2 Cell
surface events during myogenesis: immunofluorescence analysis using monoclonal antibodies.
#C
3 Differential expression of cell
surface antigens on muscle satellite cells and myoblasts.
#C
4 Cholinergic
specific nerve terminal antigens.
#C
5 Use of antibodies to purify cholinergic nerve terminals.
#NC(C) NOTES and COMMENTS related to the foregoing topics.
#NC(C)
1 An immunological approach to the cell lineage problem in the mammalian CNS.
#NC(C)
2 An enzyme
linked immunosorbent assay for calmodulin.
#NC(C)
3 Intermediate filament diversity as detected by antibodies.
#D Antibody Approaches to Membrane Components Including the T
Cell Receptor.
#D
1 Exploitation of antibodies in the study of cell membranes.
#D
2 Use of polyclonal and monoclonal antibodies in studying complement component C9 as a transmembrane protein.
#D
3 Ca2+
binding proteins located on the cytoplasmic face of the lymphocyte plasma membrane.
#D
4 The T
cell receptor.
#NC(D) NOTES and COMMENTS related to the foregoing topics.
#NC(D)
1 New light on the T
cell receptor in relation to antibody binding sites.
#NC(D)
2 Molecular nature of the T3 antigen of human T lymphocytes.
#NC(D)
3 Organization and expression of the murine T
cell receptor ?
chain gene complex.
#NC(D)
4 Antigen
specific T
cell activation.
#E Antibodies in Relation to Oncology.
#E
1 Requirements by cancer cells for polypeptide growth factors suggest new therapeutic strategies.
#E
2 Monoclonal antibodies to human tumours for targeting cytotoxic drugs.
#E
3 Antigenic modulation as a limiting factor in the treatment of B
cell lymphoma with anti
idiotype antibody.
#E
4 Tumour
associatedcarbohydrate antigens of glycoproteins.
#E
5 Glycolipid antigens: potential in cancer detection and diagnosis.
#NC(E) NOTES and COMMENTS related to the foregoing topics.
#NC(E)
1 Immune surveillance.
#NC(E)
2 WORKSHOP DISCUSSION focused on #E
4, #E
5 & #E
3.
Guidance for 'uninitiated' readers.
Corrections to Vol. 13.
#A
1 Antibody combining sites
past, present and future.
#A
2 Variability, modelling and prediction of ?
hairpins with reference to the immunoglobulin fold.
#A
3 Probing the binding sites in crystals of immunoglobulins.
#A
4 Comparative structures of mouse antibody combining sites.
#NC(A) NOTE and COMMENTS related to the foregoing topics*.
#NC(A)
1 An approach to the study of anti
protein antibody combining sites.
#B Production and Characterization of Antibodies, in Contexts such as Receptor Investigation.
#B
1 Investigating the specificity of monoclonal antibodies to protein antigens using ?
galactosidase fusion proteins.
#B
2 Antibody
screening cDNA libraries.
#B
3 Anti
receptor antibodies by the auto
anti
idiotypic route.
#B
4 Production and characterization of anti
morphine anti
idiotypic antibodies.
#B
5 Anti
idiotype antibodies for the study of membrane receptors: the double monoclonal antibody approach.
#NC(B) NOTES and COMMENTS related to the foregoing topics.
#NC(B)
1 Characterization of idiotypes and VH genes of various members of A48
idiotypic network pathway.
#NC(B)
2 Monoclonal internal image anti
idiotypic antibodies of hepatitis B surface antigen.
#NC(B)
3 Structure and expression of genes encoding IgA heavy chains.
#NC(B)
4 Human:mouse antibody
producing transfectoma cell lines.
#NC(B)
5 Different ways to modify monoclonal antibodies.
#NC(B)
6 Restructuring enzymes and antibodies.
#NC(B)
7 Dideoxy mRNA sequencing as a method to analyze antibody diversity.
#NC(B)
8 Effect of multivalent binding on dissociation of monoclonal antibodies from cell surface antigens.
#C Cytoskeletal, Myocyte and Neuronal Studies with Antibodies.
#C
1Immunological approaches and techniques employed in tubulin and microtubule research.
#C
2 Cell
surface events during myogenesis: immunofluorescence analysis using monoclonal antibodies.
#C
3 Differential expression of cell
surface antigens on muscle satellite cells and myoblasts.
#C
4 Cholinergic
specific nerve terminal antigens.
#C
5 Use of antibodies to purify cholinergic nerve terminals.
#NC(C) NOTES and COMMENTS related to the foregoing topics.
#NC(C)
1 An immunological approach to the cell lineage problem in the mammalian CNS.
#NC(C)
2 An enzyme
linked immunosorbent assay for calmodulin.
#NC(C)
3 Intermediate filament diversity as detected by antibodies.
#D Antibody Approaches to Membrane Components Including the T
Cell Receptor.
#D
1 Exploitation of antibodies in the study of cell membranes.
#D
2 Use of polyclonal and monoclonal antibodies in studying complement component C9 as a transmembrane protein.
#D
3 Ca2+
binding proteins located on the cytoplasmic face of the lymphocyte plasma membrane.
#D
4 The T
cell receptor.
#NC(D) NOTES and COMMENTS related to the foregoing topics.
#NC(D)
1 New light on the T
cell receptor in relation to antibody binding sites.
#NC(D)
2 Molecular nature of the T3 antigen of human T lymphocytes.
#NC(D)
3 Organization and expression of the murine T
cell receptor ?
chain gene complex.
#NC(D)
4 Antigen
specific T
cell activation.
#E Antibodies in Relation to Oncology.
#E
1 Requirements by cancer cells for polypeptide growth factors suggest new therapeutic strategies.
#E
2 Monoclonal antibodies to human tumours for targeting cytotoxic drugs.
#E
3 Antigenic modulation as a limiting factor in the treatment of B
cell lymphoma with anti
idiotype antibody.
#E
4 Tumour
associatedcarbohydrate antigens of glycoproteins.
#E
5 Glycolipid antigens: potential in cancer detection and diagnosis.
#NC(E) NOTES and COMMENTS related to the foregoing topics.
#NC(E)
1 Immune surveillance.
#NC(E)
2 WORKSHOP DISCUSSION focused on #E
4, #E
5 & #E
3.
Guidance for 'uninitiated' readers.
Corrections to Vol. 13.
#A Antibody Combining Sites, Especially Structure.- #A-1 Antibody combining sites - past, present and future.- #A-2 Variability, modelling and prediction of ?-hairpins with reference to the immunoglobulin fold.- #A-3 Probing the binding sites in crystals of immunoglobulins.- #A-4 Comparative structures of mouse antibody combining sites.- #NC(A) NOTE and COMMENTS related to the foregoing topics*.- #NC(A)-1 An approach to the study of anti-protein antibody combining sites.- #B Production and Characterization of Antibodies, in Contexts such as Receptor Investigation.- #B-1 Investigating the specificity of monoclonal antibodies to protein antigens using ?-galactosidase fusion proteins.- #B-2 Antibody-screening cDNA libraries.- #B-3 Anti-receptor antibodies by the auto-anti-idiotypic route.- #B-4 Production and characterization of anti-morphine anti-idiotypic antibodies.- #B-5 Anti-idiotype antibodies for the study of membrane receptors: the double monoclonal antibody approach.- #NC(B) NOTES and COMMENTS related to the foregoing topics.- #NC(B)-1 Characterization of idiotypes and VH genes of various members of A48-idiotypic network pathway.- #NC(B)-2 Monoclonal internal image anti-idiotypic antibodies of hepatitis B surface antigen.- #NC(B)-3 Structure and expression of genes encoding IgA heavy chains.- #NC(B)-4 Human:mouse antibody-producing transfectoma cell lines.- #NC(B)-5 Different ways to modify monoclonal antibodies.- #NC(B)-6 Restructuring enzymes and antibodies.- #NC(B)-7 Dideoxy mRNA sequencing as a method to analyze antibody diversity.- #NC(B)-8 Effect of multivalent binding on dissociation of monoclonal antibodies from cell surface antigens.- #C Cytoskeletal, Myocyte and Neuronal Studies with Antibodies.- #C-1Immunological approaches and techniques employed in tubulin and microtubule research.- #C-2 Cell-surface events during myogenesis: immunofluorescence analysis using monoclonal antibodies.- #C-3 Differential expression of cell-surface antigens on muscle satellite cells and myoblasts.- #C-4 Cholinergic-specific nerve terminal antigens.- #C-5 Use of antibodies to purify cholinergic nerve terminals.- #NC(C) NOTES and COMMENTS related to the foregoing topics.- #NC(C)-1 An immunological approach to the cell lineage problem in the mammalian CNS.- #NC(C)-2 An enzyme-linked immunosorbent assay for calmodulin.- #NC(C)-3 Intermediate filament diversity as detected by antibodies.- #D Antibody Approaches to Membrane Components Including the T-Cell Receptor.- #D-1 Exploitation of antibodies in the study of cell membranes.- #D-2 Use of polyclonal and monoclonal antibodies in studying complement component C9 as a transmembrane protein.- #D-3 Ca2+-binding proteins located on the cytoplasmic face of the lymphocyte plasma membrane.- #D-4 The T-cell receptor.- #NC(D) NOTES and COMMENTS related to the foregoing topics.- #NC(D)-1 New light on the T-cell receptor in relation to antibody binding sites.- #NC(D)-2 Molecular nature of the T3 antigen of human T lymphocytes.- #NC(D)-3 Organization and expression of the murine T-cell receptor ?-chain gene complex.- #NC(D)-4 Antigen-specific T-cell activation.- #E Antibodies in Relation to Oncology.- #E-1 Requirements by cancer cells for polypeptide growth factors suggest new therapeutic strategies.- #E-2 Monoclonal antibodies to human tumours for targeting cytotoxic drugs.- #E-3 Antigenic modulation as a limiting factor in the treatment of B-cell lymphoma with anti-idiotype antibody.- #E-4 Tumour-associatedcarbohydrate antigens of glycoproteins.- #E-5 Glycolipid antigens: potential in cancer detection and diagnosis.- #NC(E) NOTES and COMMENTS related to the foregoing topics.- #NC(E)-1 Immune surveillance.- #NC(E)-2 WORKSHOP DISCUSSION focused on #E-4, #E-5 & #E-3.- Guidance for 'uninitiated' readers.- Corrections to Vol. 13.
#A Antibody Combining Sites, Especially Structure.
#A
1 Antibody combining sites
past, present and future.
#A
2 Variability, modelling and prediction of ?
hairpins with reference to the immunoglobulin fold.
#A
3 Probing the binding sites in crystals of immunoglobulins.
#A
4 Comparative structures of mouse antibody combining sites.
#NC(A) NOTE and COMMENTS related to the foregoing topics*.
#NC(A)
1 An approach to the study of anti
protein antibody combining sites.
#B Production and Characterization of Antibodies, in Contexts such as Receptor Investigation.
#B
1 Investigating the specificity of monoclonal antibodies to protein antigens using ?
galactosidase fusion proteins.
#B
2 Antibody
screening cDNA libraries.
#B
3 Anti
receptor antibodies by the auto
anti
idiotypic route.
#B
4 Production and characterization of anti
morphine anti
idiotypic antibodies.
#B
5 Anti
idiotype antibodies for the study of membrane receptors: the double monoclonal antibody approach.
#NC(B) NOTES and COMMENTS related to the foregoing topics.
#NC(B)
1 Characterization of idiotypes and VH genes of various members of A48
idiotypic network pathway.
#NC(B)
2 Monoclonal internal image anti
idiotypic antibodies of hepatitis B surface antigen.
#NC(B)
3 Structure and expression of genes encoding IgA heavy chains.
#NC(B)
4 Human:mouse antibody
producing transfectoma cell lines.
#NC(B)
5 Different ways to modify monoclonal antibodies.
#NC(B)
6 Restructuring enzymes and antibodies.
#NC(B)
7 Dideoxy mRNA sequencing as a method to analyze antibody diversity.
#NC(B)
8 Effect of multivalent binding on dissociation of monoclonal antibodies from cell surface antigens.
#C Cytoskeletal, Myocyte and Neuronal Studies with Antibodies.
#C
1Immunological approaches and techniques employed in tubulin and microtubule research.
#C
2 Cell
surface events during myogenesis: immunofluorescence analysis using monoclonal antibodies.
#C
3 Differential expression of cell
surface antigens on muscle satellite cells and myoblasts.
#C
4 Cholinergic
specific nerve terminal antigens.
#C
5 Use of antibodies to purify cholinergic nerve terminals.
#NC(C) NOTES and COMMENTS related to the foregoing topics.
#NC(C)
1 An immunological approach to the cell lineage problem in the mammalian CNS.
#NC(C)
2 An enzyme
linked immunosorbent assay for calmodulin.
#NC(C)
3 Intermediate filament diversity as detected by antibodies.
#D Antibody Approaches to Membrane Components Including the T
Cell Receptor.
#D
1 Exploitation of antibodies in the study of cell membranes.
#D
2 Use of polyclonal and monoclonal antibodies in studying complement component C9 as a transmembrane protein.
#D
3 Ca2+
binding proteins located on the cytoplasmic face of the lymphocyte plasma membrane.
#D
4 The T
cell receptor.
#NC(D) NOTES and COMMENTS related to the foregoing topics.
#NC(D)
1 New light on the T
cell receptor in relation to antibody binding sites.
#NC(D)
2 Molecular nature of the T3 antigen of human T lymphocytes.
#NC(D)
3 Organization and expression of the murine T
cell receptor ?
chain gene complex.
#NC(D)
4 Antigen
specific T
cell activation.
#E Antibodies in Relation to Oncology.
#E
1 Requirements by cancer cells for polypeptide growth factors suggest new therapeutic strategies.
#E
2 Monoclonal antibodies to human tumours for targeting cytotoxic drugs.
#E
3 Antigenic modulation as a limiting factor in the treatment of B
cell lymphoma with anti
idiotype antibody.
#E
4 Tumour
associatedcarbohydrate antigens of glycoproteins.
#E
5 Glycolipid antigens: potential in cancer detection and diagnosis.
#NC(E) NOTES and COMMENTS related to the foregoing topics.
#NC(E)
1 Immune surveillance.
#NC(E)
2 WORKSHOP DISCUSSION focused on #E
4, #E
5 & #E
3.
Guidance for 'uninitiated' readers.
Corrections to Vol. 13.
#A
1 Antibody combining sites
past, present and future.
#A
2 Variability, modelling and prediction of ?
hairpins with reference to the immunoglobulin fold.
#A
3 Probing the binding sites in crystals of immunoglobulins.
#A
4 Comparative structures of mouse antibody combining sites.
#NC(A) NOTE and COMMENTS related to the foregoing topics*.
#NC(A)
1 An approach to the study of anti
protein antibody combining sites.
#B Production and Characterization of Antibodies, in Contexts such as Receptor Investigation.
#B
1 Investigating the specificity of monoclonal antibodies to protein antigens using ?
galactosidase fusion proteins.
#B
2 Antibody
screening cDNA libraries.
#B
3 Anti
receptor antibodies by the auto
anti
idiotypic route.
#B
4 Production and characterization of anti
morphine anti
idiotypic antibodies.
#B
5 Anti
idiotype antibodies for the study of membrane receptors: the double monoclonal antibody approach.
#NC(B) NOTES and COMMENTS related to the foregoing topics.
#NC(B)
1 Characterization of idiotypes and VH genes of various members of A48
idiotypic network pathway.
#NC(B)
2 Monoclonal internal image anti
idiotypic antibodies of hepatitis B surface antigen.
#NC(B)
3 Structure and expression of genes encoding IgA heavy chains.
#NC(B)
4 Human:mouse antibody
producing transfectoma cell lines.
#NC(B)
5 Different ways to modify monoclonal antibodies.
#NC(B)
6 Restructuring enzymes and antibodies.
#NC(B)
7 Dideoxy mRNA sequencing as a method to analyze antibody diversity.
#NC(B)
8 Effect of multivalent binding on dissociation of monoclonal antibodies from cell surface antigens.
#C Cytoskeletal, Myocyte and Neuronal Studies with Antibodies.
#C
1Immunological approaches and techniques employed in tubulin and microtubule research.
#C
2 Cell
surface events during myogenesis: immunofluorescence analysis using monoclonal antibodies.
#C
3 Differential expression of cell
surface antigens on muscle satellite cells and myoblasts.
#C
4 Cholinergic
specific nerve terminal antigens.
#C
5 Use of antibodies to purify cholinergic nerve terminals.
#NC(C) NOTES and COMMENTS related to the foregoing topics.
#NC(C)
1 An immunological approach to the cell lineage problem in the mammalian CNS.
#NC(C)
2 An enzyme
linked immunosorbent assay for calmodulin.
#NC(C)
3 Intermediate filament diversity as detected by antibodies.
#D Antibody Approaches to Membrane Components Including the T
Cell Receptor.
#D
1 Exploitation of antibodies in the study of cell membranes.
#D
2 Use of polyclonal and monoclonal antibodies in studying complement component C9 as a transmembrane protein.
#D
3 Ca2+
binding proteins located on the cytoplasmic face of the lymphocyte plasma membrane.
#D
4 The T
cell receptor.
#NC(D) NOTES and COMMENTS related to the foregoing topics.
#NC(D)
1 New light on the T
cell receptor in relation to antibody binding sites.
#NC(D)
2 Molecular nature of the T3 antigen of human T lymphocytes.
#NC(D)
3 Organization and expression of the murine T
cell receptor ?
chain gene complex.
#NC(D)
4 Antigen
specific T
cell activation.
#E Antibodies in Relation to Oncology.
#E
1 Requirements by cancer cells for polypeptide growth factors suggest new therapeutic strategies.
#E
2 Monoclonal antibodies to human tumours for targeting cytotoxic drugs.
#E
3 Antigenic modulation as a limiting factor in the treatment of B
cell lymphoma with anti
idiotype antibody.
#E
4 Tumour
associatedcarbohydrate antigens of glycoproteins.
#E
5 Glycolipid antigens: potential in cancer detection and diagnosis.
#NC(E) NOTES and COMMENTS related to the foregoing topics.
#NC(E)
1 Immune surveillance.
#NC(E)
2 WORKSHOP DISCUSSION focused on #E
4, #E
5 & #E
3.
Guidance for 'uninitiated' readers.
Corrections to Vol. 13.
#A Antibody Combining Sites, Especially Structure.- #A-1 Antibody combining sites - past, present and future.- #A-2 Variability, modelling and prediction of ?-hairpins with reference to the immunoglobulin fold.- #A-3 Probing the binding sites in crystals of immunoglobulins.- #A-4 Comparative structures of mouse antibody combining sites.- #NC(A) NOTE and COMMENTS related to the foregoing topics*.- #NC(A)-1 An approach to the study of anti-protein antibody combining sites.- #B Production and Characterization of Antibodies, in Contexts such as Receptor Investigation.- #B-1 Investigating the specificity of monoclonal antibodies to protein antigens using ?-galactosidase fusion proteins.- #B-2 Antibody-screening cDNA libraries.- #B-3 Anti-receptor antibodies by the auto-anti-idiotypic route.- #B-4 Production and characterization of anti-morphine anti-idiotypic antibodies.- #B-5 Anti-idiotype antibodies for the study of membrane receptors: the double monoclonal antibody approach.- #NC(B) NOTES and COMMENTS related to the foregoing topics.- #NC(B)-1 Characterization of idiotypes and VH genes of various members of A48-idiotypic network pathway.- #NC(B)-2 Monoclonal internal image anti-idiotypic antibodies of hepatitis B surface antigen.- #NC(B)-3 Structure and expression of genes encoding IgA heavy chains.- #NC(B)-4 Human:mouse antibody-producing transfectoma cell lines.- #NC(B)-5 Different ways to modify monoclonal antibodies.- #NC(B)-6 Restructuring enzymes and antibodies.- #NC(B)-7 Dideoxy mRNA sequencing as a method to analyze antibody diversity.- #NC(B)-8 Effect of multivalent binding on dissociation of monoclonal antibodies from cell surface antigens.- #C Cytoskeletal, Myocyte and Neuronal Studies with Antibodies.- #C-1Immunological approaches and techniques employed in tubulin and microtubule research.- #C-2 Cell-surface events during myogenesis: immunofluorescence analysis using monoclonal antibodies.- #C-3 Differential expression of cell-surface antigens on muscle satellite cells and myoblasts.- #C-4 Cholinergic-specific nerve terminal antigens.- #C-5 Use of antibodies to purify cholinergic nerve terminals.- #NC(C) NOTES and COMMENTS related to the foregoing topics.- #NC(C)-1 An immunological approach to the cell lineage problem in the mammalian CNS.- #NC(C)-2 An enzyme-linked immunosorbent assay for calmodulin.- #NC(C)-3 Intermediate filament diversity as detected by antibodies.- #D Antibody Approaches to Membrane Components Including the T-Cell Receptor.- #D-1 Exploitation of antibodies in the study of cell membranes.- #D-2 Use of polyclonal and monoclonal antibodies in studying complement component C9 as a transmembrane protein.- #D-3 Ca2+-binding proteins located on the cytoplasmic face of the lymphocyte plasma membrane.- #D-4 The T-cell receptor.- #NC(D) NOTES and COMMENTS related to the foregoing topics.- #NC(D)-1 New light on the T-cell receptor in relation to antibody binding sites.- #NC(D)-2 Molecular nature of the T3 antigen of human T lymphocytes.- #NC(D)-3 Organization and expression of the murine T-cell receptor ?-chain gene complex.- #NC(D)-4 Antigen-specific T-cell activation.- #E Antibodies in Relation to Oncology.- #E-1 Requirements by cancer cells for polypeptide growth factors suggest new therapeutic strategies.- #E-2 Monoclonal antibodies to human tumours for targeting cytotoxic drugs.- #E-3 Antigenic modulation as a limiting factor in the treatment of B-cell lymphoma with anti-idiotype antibody.- #E-4 Tumour-associatedcarbohydrate antigens of glycoproteins.- #E-5 Glycolipid antigens: potential in cancer detection and diagnosis.- #NC(E) NOTES and COMMENTS related to the foregoing topics.- #NC(E)-1 Immune surveillance.- #NC(E)-2 WORKSHOP DISCUSSION focused on #E-4, #E-5 & #E-3.- Guidance for 'uninitiated' readers.- Corrections to Vol. 13.